My watch list
my.bionity.com  
Login  

GVK Biosciences opens new Clinical Pharmacology Unit in Ahmedabad

New facility commissioned to meet increasing business demand

19-Mar-2010

GVK Biosciences (GVK BIO) announced that it has commissioned its new clinical pharmacology unit (CPU) in Ahmedabad, India. The Ahmedabad CPU adds 110 beds to GVK BIO’s existing capacity of 144 beds. The new CPU will conduct a variety of studies in healthy volunteers.

Ahmedabad was the most preferred and logical destination for expansion considering the volunteer pool accessibility and proximity to about 10 CROs and leading Pharma companies. With 3 clinical wards and 110 beds, the Unit is state-of-the-art and designed to suit all regulatory requirements. It also has special housing facilities for female volunteers. Key features of this Unit include access to special population like young women, post-menopausal women, diseased population and access to about 12,000 healthy volunteers.

“The opening of the new GVK BIO Clinical Pharmacology unit reflects our commitment to offer faster recruitment solutions to our customers. The facility has been audited by the DCGI and we have initiated our first study at the Ahmedabad facility”, said Manni Kantipudi, President, GVK Biosciences.

Facts, background information, dossiers
More about GVK Biosciences
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE